Search Results
508 results found for "pedsFACIT-F"
- NFHSI-18 Languages
BACK NFHSI-18 Languages Arabic Chinese – Simplified Dutch English French German Hebrew Hungarian Italian
- PROMIS SF v1.0-Dyspnea-Severity 5a
Users are not permitted to translate the PROMIS-SF-v1.0-Dyspnea-Severity 5a without permission from FACIT.org Permission from FACIT.org to translate the PROMIS-SF-v1.0-Dyspnea-Severity 5a may also be contingent For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement and related functional limitations. LICENSE THIS MEASURE Related Measures Related Measures FACIT-Dyspnea Functional Assessment of Chronic
- PROMIS Item Bank v1.0 - Dyspnea Severity
FACIT.org. Permission from FACIT.org to translate the PROMIS Item Bank v1.0 - Dyspnea Severity may also be contingent For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement and related functional limitations. LICENSE THIS MEASURE Related Measures Related Measures FACIT-Dyspnea Functional Assessment of Chronic
- Administration
Administration OF THE FACIT MEASURES Ideally, FACIT measures are self-administered. The original FACIT measure administration was via paper format, and most of the early measures were validated with assistance from an objective person (i.e., not a friend or family member, but a staff person) Self-administration with assistance from a familiar person Proxy report from a familiar person Skipping items versus making A guidance for electronic presentation of FACIT items can be found here .
- Scoring
Scoring OF THE FACIT MEASURES For all FACIT measures, higher scores are better than lower scores. For any FACIT measure, subscale scores are calculated by first reversing negatively stated-items (subtracting FWB. It is the sum of the Physical Well-Being (PWB), Functional Well-Being (FWB), and additional concerns FACIT.
- BESS
RELATED MEASURES: FACT-B , FBSI , NFBSI-16 DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Users are not permitted to translate the BESS without prior permission from FACIT.org. For commercial use, FACITtrans is the approved translation vendor of the BESS. LICENSE THIS MEASURE Related Measures Related Measures FACT-B Functional Assessment of Cancer Therapy - Breast LEARN MORE FBSI FACT Breast Symptom Index LEARN MORE NFBSI-16 National Comprehensive Cancer
- NFPSI-17 Languages
17 Languages Arabic Bulgarian Chinese - Simplified Chinese - Traditional Czech Danish Dutch English Finnish French German Hebrew Hungarian Italian Japanese Korean Norwegian Polish Portuguese Russian Spanish Swedish
- NFBrSI-24 Languages
Languages Arabic Bengali Bulgarian Chinese - Simplified Chinese - Traditional Croatian Dutch English French
- NFLSI-17
It was developed with input from 50 patients with advanced lung cancer who were recruited from National Patients also completed the Functional Assessment of Cancer Therapy-Lung (FACT-L), which was used to RELATED MEASURES: FACT-L , FLSI , FLSI-12 , FACT-LCS , FACT-PSI DOWNLOAD MEASURE IN ENGLISH DOWNLOAD Users are not permitted to translate the NFLSI-17 without permission from FACIT.org. and availability of FACIT staff.
- PRAI
, FACT-G7 , FACT-BP DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available Users are not permitted to translate the PRAI without prior permission from FACIT.org. LICENSE THIS MEASURE Related Measures Related Measures FACT-G Functional Assessment of Cancer Therapy - General LEARN MORE FACT-G7 Functional Assessment of Cancer Therapy – General – 7 Item Version LEARN MORE FACT-BP Functional Assessment of Cancer Therapy - Bone Pain LEARN MORE
- NFOSI-18
RELATED MEASURES: FACT-O , FOSI , FACT-G DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Users are not permitted to translate the NFOSI-18 without permission from FACIT.org. Permission from FACIT.org to translate the NFOSI-18 may also be contingent upon timeline expectations and availability of FACIT staff. Version LEARN MORE FACT-G Functional Assessment of Cancer Therapy – General LEARN MORE
- OMDQ
official, final version developed by Amgen. Users are not permitted to translate the OMDQ without prior permission from FACIT.org. For commercial use, FACITtrans is the approved translation vendor of the OMDQ. There is no fee for use of the English version, but a license should be obtained. All of the information provided in the form will be kept strictly confidential.
